Saturday, 27 May 2017

Australia News

  • QIC Consortium to buy Australian Icon Group for A$1 Billion

    Australia |  News | 0 Comment

    A consortium comprising QIC Ltd., Goldman Sachs Group Inc.’s private equity arm and China’s Pagoda Investment agreed to buy Australian healthcare company Icon Cancer Care Group....Read more

  • Funds for new stroke research

    Australia |  News | 0 Comment

    Stroke Foundation will provide more than $205,000 to eight Australian researchers, underpinning new research projects and supporting future leaders in stroke. The Stroke Foundation is dedic...Read more

  • New imaging technique for removing tumors

    Australia |  News | 0 Comment

    Researchers at BRITElab at Harry Perkins Institute of Medical Research and the University of Western Australia have developed an imaging technique that assists surgeons to effectively remov...Read more

  • Ex-Telstra executive Ballantyne takes charge of Healthscope

    Australia |  News | 0 Comment

    Gordon Ballantyne, previously at Telstra, is joining the top ranks of Australia’s healthcare sector following the latest chief executive exit from the volatile industry. Mr Ballantyn...Read more

  • Australia slashes prescription drug prices

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Bringing in much needed relief for millions of consumers, the Australian government announced that is reducing the price of 1,100 medicine brands listed on the Pharmaceutical Ben...Read more

  • Pfizer announces closure of its Australian facility

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Global pharma giant Pfizer recently announced its plans to close an Australian manufacturing plant by 2021 that produces, an intermediate of a biosimilar to Amgen's Neulasta (peg...Read more

  • Bionomics progresses to develop novel drug for CNS

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Bionomics, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and c...Read more

  • Australian research receives A$125 mn funding boost

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: In a bid to further boost research and development, Australian government has announced afresh series of funding for the country's research activities. The National Health and Me...Read more

  • Medicines Australia, MTP Connect ink MoU to boost innovation

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: In a bid to boost the country's pharmaceutical sector and encourage new drug invention, The Medical Technologies, Biotechnologies and Pharmaceuticals Industry Growth Centre - and...Read more

  • Google launches health cards in Australia

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Making a foray into healthcare, Google has recently launched health condition cards in Australia, that is touted to accurately answer the common health conditions queries. They w...Read more

  • Mainstay Medical seeks Australian approval to sell ReActiv8

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: As per reports, global medical device firm Mainstay Medical has sought approval to market i its implantable device for chronic low back pain in Australia. The Dublin company is s...Read more

  • Australia approves drug that can 'melt away' cancer cells

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australian authorities have just approved a new drugvenetoclax that is touted to have the power to "melt away" certain advanced forms of chronic lymphocytic leukaemia (CLL). Leuk...Read more

  • GSK to shut down its Sydney plant by 2020

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: According to reports, British drug giant GlaxoSmithKline will close its Sydney plant by 2020 after a review determined it was not competitive long term. The move will impact near...Read more

  • Australia changes drug approval norms to speed up approval process

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: With a view to speed up the approval process and improve access to breakthrough drugs, the Australian federal government is implementing new measures for approval of new medicine...Read more

  • Hypoglycaemia monitor for diabetics wins award

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    AIMEDICS, an Australian medical device company, has come up with a device that help people with insulin-dependent diabetes mellitus (IDDM) by detecting and preventing sleep-time hypoglycem...Read more

  • Research and innovation critical for productivity'

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The report, entitled 'The role of science research and technology in lifting Australian productivity,' makes 25 key findings about Australia's current performance and outlines op...Read more

  • Phosphagenics patch delivers Oxymorphone for 72 hours

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australian drug delivery technology company, Phosphagenics highlighted that it has achieved all end points of its important phase I trial of its oxymorphone patch by successfully...Read more

  • New Australian facility to translate research into products

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australian life sciences researchers will now be able to translate their discoveries into commercial products faster with the newly established Queensland Node of the Therapeutic...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls